Why are ONGC and Oil India surging while OMCs face massive under-recovery fears? Here are the 3 biggest concerns for…
Share market today, May 11: Markets slump 1.5% after PM Modi’s advisory, with Sensex losing 1,300 points; stay updated on…
Over 400 firms, including Cipla, Airtel & Tata Steel, to unveil Q4 results this week. Track key announcements and dividend…
Domestic investors are now the biggest force in Indian equities as FIIs retreat. Motilal Oswal identifies four high-conviction stock picks…
Missile production opens up, ₹2.2 lakh crore defence push builds momentum, and two stocks surge up to 50%. But can…
TVS Motor posts 7% sales growth in April, led by scooters and EVs, though supply chain constraints impacted dispatch volumes…
Over 200 companies, including Vedanta and HUL, will announce key Q4FY26 results this week. Stay updated on dividends and market…
The Q4 EBITDA stood at Rs 938.7 crore, a jump of 142% YoY. The EBITDA margin expanded 320 basis points…
IEX plunges on regulatory shock while BHEL hits a 52-week high; Trent, ICICI Bank and Apollo Micro Systems drive sharp…
A look at fundamentally strong largecap stocks bought by DIIs.
India’s ₹2.38L cr defense wave shifts to execution. Beyond the giants, 3 niche firms are building the ‘brains’ for missiles…
A hidden data centre play at Palava could transform Lodha Developers’ growth story, with Jefferies seeing massive upside ahead.
Motilal Oswal names 6 top auto and ancillary stocks for Q4 recovery—explore their picks and growth outlook now!
Emkay Global retains Buy on KPIL with a target of Rs 1,450, citing strong T&D growth drivers; discover if this…
India approves Rs 2.38 trillion defence deals, spotlighting BEL, HAL, L&T, and GRSE—track these stocks for future order wins!
A sharp sell-off gripped markets as pharma stocks plunged on US tariff fears and rising crude prices dragged key sectors,…
Strong BEL order inflows impress Street, but rich valuations keep upside limited as Nomura stays cautious.
Pharma stocks fall as Nifty Pharma drops 3%. Sun Pharma, Cipla slide amid US tariff fears and export risk concerns.